Based on the observation that TGF-β increases the expression of the inhibitor NKG2A in HCC, a CAR NK cell engineered to convert the TGF-β-induced suppressive signal into an activating signal was developed [88,90]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.